NCT01283958View on ClinicalTrials.gov

The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

May 31, 2010

Conditions

Eisenmenger's Syndrome

All Listed Sponsors

lead

Gachon University Gil Medical Center

OTHER

NCT01283958 - The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome | Biotech Hunter | Biotech Hunter